An evaluation of the efficacy of the toe brachial index measuring vascular involvement in systemic sclerosis and other connective tissue diseases

Clinical and Experimental Rheumatology

Volumn 27, Issue 3 SUPPL. 54, 2009, Pages

  Muro, Yoshinao ^a   Sugiura, Kazumitsu ^a   Morita, Yukiko ^a   Tomita, Yasushi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood pressure; Logistic regression analysis; Peripheral vascular disease; Skin ulcer; Systemic sclerosis; Toe brachial index

Indexed keywords

ALPHA TOCOPHEROL; ANTITHROMBOCYTIC AGENT; BETA2 GLYCOPROTEIN 1 ANTIBODY; CALCIUM ANTAGONIST; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PREDNISOLONE; PROSTAGLANDIN DERIVATIVE;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD VESSEL PARAMETERS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SKIN ULCER; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TOE BRACHIAL INDEX;

ADULT; AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; BLOOD PRESSURE; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SCLERODERMA, SYSTEMIC; TOES; YOUNG ADULT;

EID: 70350291551     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. TUFFANELLI DL, WINKELMANN RK: Systemic scleroderma: a clinical study of 727 cases. Arch Dermatol 1961; 84: 359-371
2. KARASSA FB, IOANNIDIS JPA: Mortality in systemic sclerosis. Clin Exp Rheumatol 2008; 26: S85-93.
3. VALENTINI G, CERINIC M: Disease-specific quality indicators, guidelines and outcome measures in scleroderma. Clin Exp Rheumatol 2007; 25: S159-62.
4. HIRSCH AT, CRIQUI MH, TREAT-JACOBSON D et al.: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324 (Pubitemid 33015522)
5. STOFFERS J, KAISER V, KESTER A, SCHOUTEN H, KNOTTNERUS A: Peripheral arterial occlusive disease in general practice: the reproducibility of the ankle-arm systolic pressure ratio. Scand J Prim Health Care 1991; 9: 109-114
6. CRIQUI MH: Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease. Am J Cardiol 2001; 88: 43J-47J.
7. CARTER SA, LEZACK JD: Digital systolic pressures in the lower limb in arterial disease. Circulation 1971; 43: 905-914
8. ORCHARD TJ, STRANDNESS DE JR: Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association. Circulation 1993; 88: 819-828
9. MAYFIELD JA, REIBER GF, SANDERS LJ, JANISSE D, POGACH LM: Preventive foot care in people with diabetes. Diabetes Care 1998; 21: 2161-2179
10. YOUNG MJ, ADAMS JE, ANDERSON GF, BOULTON AJM, CAVANAGH PR: Medical arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 1993; 36: 615-621
11. LEZACK JD, CARTER SA: The relationship of distal systolic pressures to the clinical and angiographic findings in limbs with arterial occlusive disease. Scand J Clin Lab Invest 1973; 31 (Suppl. 128): 97-101.
12. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE AMERICAN RHEUMATISM ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590
13. LEROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205
14. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324
15. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
16. FUJITA M, IGARASHI T, KURAI T, SAKANE M, YOSHINO S, TAKAHASHI H: Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol 2005; 140: 808-813 (Pubitemid 41727672)
17. BOHAN A, PETER JB: Polymyositis and dermatomyositis (first of two parts). N Eng J Med 1975; 292: 344-347
18. BOHAN A, PETER JB: Polymyositis and dermatomyositis (second of two parts). N Eng J Med 1975; 292: 403-407
19. TAKEHARA K, SATO S: The clarification of pathogenesis and the development of therapy in systemic sclerosis: the classification of severity and the guideline for treatment (2007). Edited by, a research project for systemic sclerosis supported by Japanese Ministry of Health and Welfare; 2007.
20. MEDSGER TA JR, BOMBARDIERI S, CZIRJAK L, SCORZA R, DELLA ROSSA A, BENCIVELLI W: Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S42-6.
21. ANDERSON ME, MOORE TL, LUNT M, HERRICK AL: The 'distal-dorsal difference': a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon. Rheumatology (Oxford) 2007; 46: 533-538
22. NORGREN L, HIATT WR, DORMANDY JA, NEHLER MR, HARRIS KA, FOWKES FG: TASC II Working Group: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 (Suppl. S): S5-67.
23. BONHAM PA: Get the LEAD out: noninvasive assessment for lower extremity arterial disease using ankle brachial index and toe brachial index measurements. J Wound Ostomy Continence Nurs 2006; 33: 30-41.
24. CRITICAL LEG ISCHAEMIA PREVENTION STUDY (CLIPS) GROUP, CATALANO M, BORN G, PETO R: Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. J Intern Med 2007; 261: 276-284
25. ZIMMERMANN C, STEINER G, SKRINER K, HASSFELD W, PETERA P, SMOLEN JS: The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome. Arthritis Rheum 1998; 41: 1938-1945
26. MORITA Y, MURO Y, SUGIURA K, TOMITA Y: Anti-cyclic citrullinated peptide antibody in systemic sclerosis. Clin Exp Rheumatol 2008; 26: 542-547
27. HORIKI T, MORIUCHI J, TAKAYA M et al.: The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Clinical and immunogenetic features suggest a distinct entity. Arthritis Rheum 1996; 39: 152-156 (Pubitemid 126575934)
28. MORITA Y, MURO Y, SUGIURA K, TOMITA Y, TAMAKOSHI K: Results of the Health Assessment Questionnaire for Japanese patients with systemic sclerosis - measuring functional impairment in systemic sclerosis versus other connective tissue diseases. Clin Exp Rheumatol 2007; 25: 367-372
29. JOHNSON SR, HAWKER GA, DAVIS AM: The Health Assessment Questionnaire Disability Index and Scleroderma Health Assessment Questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum 2005; 53: 256-262
30. KIDO M, TAKEUCHI S, HAYASHIDA S, URABE K, SAWADA R, FURUE M: Assessment of abnormal blood flow and efficacy of treatment in patients with systemic sclerosis using a newly developed microwireless laser Doppler flowmeter and arm-raising test. Br J Dermatol 2007; 157: 690-697
31. TIMÁR O, SOLTÉSZ P, SZAMOSI S et al.: Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol 2008; 35: 1329-1333